JOURNAL OFVIROLOGY, Dec. 1993,p. 7149-716(0 0022-538X/93/127149-12$02.00/0
Copyright
© 1993, AmericanSociety
forMicrobiology
Isolation of
a
Herpes
Simplex Virus
Type 1
Mutant
with
a
Deletion in the Virion
Host
Shutoff
Gene
and
Identification
of
Multiple
Forms
of the vhs
(UL41)
Polypeptide
G. SULLIVAN READ,* BRADLEY M. KARR,AND KIMBERLI KNIGHT
DivisionofCell Biology and Biophysics, School of Biological Sciences, University of Missouri-Kansas City, KansasCity, Missouri 64110-2499
Received 2July 1993/Accepted 14 September 1993
The virion host shutoff (vhs)gene(UL41) of herpes simplex virustype1(HSV-1) encodesavirioncomponent
that induces degradation of host mRNAs and the shutoff ofmosthostprotein synthesis. Subsequently, the vhs protein accelerates the turnoverof all kinetic classes of viral mRNA. Toidentify the vhs (UL41) polypeptide withininfected cells and virions, antisera raised againstaUL41-lacZ fusion proteinwereusedtocharacterize the polypeptides encoded by wild-type HSV-1 andtwomutants:vhsl,a previously characterizedmutantthat lacks detectablevirion host shutoff activity, and vhs-ASma,a newly constructedmutantcontainingadeletion
of196 codons from UL41. Two forms of the vhs (UL41) polypeptidewereidentified in cells infected with the wild-type virus or vhsl. Wild-type HSV-1 produced a major 58-kDa polypeptide, aswell as a less abundant
59.5-kDa form of the protein, while vhsl produced 57- and 59-kDa polypeptides that were approximately
equally abundant. Although for either virus, both forms of the proteinwerephosphorylated, they differed in the
extent ofphosphorylation. While both vhs polypeptideswerefound in infectedcells, only the faster migrating,
less phosphorylated form was incorporated into virions. vhs-ASma encoded a smaller, 31-kDa polypeptide
which, althoughpresentininfected cells,wasnotincorporated into virions. The results identify multiple forms ofthe vhs (UL41) polypeptide and suggestthatposttranslational processing affects its packaging into virions,
aswell asits abilitytoinduce mRNAdegradation. Controls of mRNA stability play an important role in
regulating the expression ofmanymammaliangenes(2, 4, 5, 9,
10, 22, 44, 49). During lytic infections with herpes simplex virus
type 1 (HSV-1), the half-lives of both viral and cellular mRNAs
are negatively regulated by the product of the HSV-1 virion
host shutoff(vhs) gene (13, 16, 17, 31, 40, 41, 45, 52, 55). At
early times after infection, copies of the vhs polypeptide that
enter the cell as components of the infecting virion induce rapid degradation of cellular mRNAs and the concomitant shutoff of most host protein synthesis (15, 52, 55). Subse-quently, after theonsetofviralgeneexpression, the vhsprotein
accelerates turnover ofviral mRNAs belonging to all kinetic classes of viral mRNA (30, 31, 40, 41, 45, 55). Thus, mutants
encoding a defective vhs protein are defective in virion host
shutoff and produce viral mRNAs with substantially longer half-lives than those of the wild-type virus (30, 31, 40, 41, 45, 55). The vhs function, therefore, appears to accelerate the
turnover of most polyadenylated mRNAs, regardless of whethertheyareof hostorviralorigin (30, 31, 40, 41, 55). As
such, the levels of host and viral mRNAs appeartobe the net
result ofabalance between gene-specific controls of
transcrip-tion andmRNAprocessing (38, 51),onthe onehand, and the
generalized vhs-induced turnover ofpolyadenylated mRNAs
on the other.
Despite a number ofstudies delineating the role of the vhs function during lytic infections and the availability of vhs
mutants, verylittle is known concerning the vhspolypeptide. Thepublished data indicating that the vhs function ismediated byavirioncomponentarethreefold.(i) Efficient host shutoff is
induced by virions that have been inactivated by exposureto
UVlight (13, 15, 17, 52, 55). (ii) vhs-induced destabilization of
*Correspondingauthor.
host mRNAsoccurs following infection of cells with wild-type
virus in the presence of drugs that block either de novo
transcription or translation (52, 55). (iii) HSV infection of enucleated cytoplasts results in rapid inhibition of protein synthesis, although mock-infected cytoplasts continue to
syn-thesizeproteinsforaprolonged interval (17). Mappingof the
mutation carried by mutant vhsl to the UL41 open reading
frame allowed identification of the vhs gene (33) and the
prediction that the primary translation product of the vhs mRNA is a 55-kDa polypeptide (36). This predictionwas in close agreement with the earlierfinding that invitro transla-tion ofanmRNAmappingtowhatwaslater showntobeUL41 resulted in production of a polypeptide with an apparent
molecular mass of 58 kDa (1, 18). Recently, Smibert and
coworkersidentifieda58-kDapolypeptidewithininfected cells
thatreactswith antiserumprepared againstasynthetic peptide
correspondingto amino acids 333 through347 ofUL41 (54). However, despite this progress, many questions remain
con-cerning thenatureandfunctioningof the vhs(UL41) protein. In this report, we describe the identification of multiple forms of the vhs (UL41) polypeptide by a combination of genetic and immunologic techniques. First, we constructed a mutant, vhs-ASma, containing a deletion of 196codons from
UL41 which, therefore, encodes a vhs polypeptide with in-creased electrophoretic mobility. Next,antisera raised against
abacteriallyexpressed UL41-lacZfusion proteinwereusedto
analyzethe vhspolypeptidesencodedby wild-typeHSV-1 and vhs-ASma,aswellasbyvhsl,apreviouslycharacterizedmutant that lacks detectable virion host shutoffactivity (29, 30, 40, 41, 45). Immunoprecipitation and immunoblotting experiments revealed two forms of the vhs (UL41) polypeptide in cells infected withwild-typeHSV-1 orvhsl. Cells infectedwith the
wild-typevirus containedamajor58-kDa polypeptide, aswell as a less abundant 59.5-kDa form of the protein, while vhsl 7149
Vol.67, No. 12
on November 9, 2019 by guest
http://jvi.asm.org/
7150 READ ET AL.
produced 57- and 59-kDa vhs(UL41) polypeptides thatwere
approximately equally abundant. For both viruses, both forms of the protein were phosphorylated, although to different
extents. Interestingly, although both vhs polypeptides were
present within infected cells, only the faster migrating, less phosphorylated form was incorporated into progeny virions.
vhs-ASma encoded a smaller, 31-kDa polypeptide which,
al-though readily detectable within infected cells,wasnot pack-aged into virions. The results identifyatleasttwoformsofthe vhs (UL41) polypeptide within HSV-1-infected cells and
sug-gest thatposttranslational modifications are important for its
incorporation into virus and possibly for its ability to induce mRNAdegradation.
MATERIALS AND METHODS
Cells and virus.Procedures for the growth and maintenance of Vero cells have been described previously (29, 40, 41). Stocks of the wild-type strain of HSV-1 (KOS) and mutants
vhsl, ts701, and vhs-ASma were prepared as described in
previous reports (29, 40, 41). vhsl exhibits a defectivevirion host shutofffunction andgrowswellat alltemperaturesfrom 34to390C(45). Mutantts701 containsatemperature-sensitive
mutation in the UL42openreadingframe (35). Itwasprovided
by Priscilla Schaffer.
Plasmids. (i) Plasmids encoding wild-type and mutantvhs
genes. Plasmid pSG124 contains EcoRI fragment A (0.49 to
0.63 map units) of wild-type HSV-1 (KOS) cloned into the
EcoRI site of pBR325 (19). Itwasprovided by Myron Levine
and Rozanne Sandri-Goldin. To construct plasmid pHS, the HindIII-SalI fragment, spanning map coordinates 0.592 to
0.614, was excised from pSG124 and inserted between the
HindIII andSall sites of Bluescript KS (Stratagene, La Jolla, Calif.). As is shown in Fig. 1, the insert in pHS contains the entire vhs gene(UL41) and portions of flankingopenreading frames UL39, UL40, and UL42 (1, 18, 36, 37). In accord with earlier results (35), pHS is able to rescue the
temperature-sensitivemutation carriedbyts701.
pHS contains three SmaI sites, two within the vhs gene
(UL41),separated by 588 bp,andonewithin thepolylinker of the vector. To construct pHS-ASma, pHS was partially
di-gested with SmaI to remove the 588-bp SmaI fragment and
then recircularizedbytreatmentwith T4DNAligase (Fig. 1). (ii) Plasmid encoding the UL41-lacZ fusion protein. Con-struction ofplasmid pBK1, which encodes aUL41-lacZfusion
protein, is diagrammed in Fig. 1. As shown in Fig. 1, pN237 contains thesyntheticoligonucleotide
5' AAG CTT AAT TGA ATT CAA TTA AGC TT 3' 3' TTC GAA TTA ACT TAA GTT AAT TCG AA 5'
inserted into thesingle NruI siteinUL41 ofpHS (42). Among other features, the oligonucleotide contains a central EcoRI site. ToconstructpBK1, a 1,737-bp EcoRI-PstI fragmentthat contains a portion of the oligonucleotide plus codons 239
through 489 of wild-type UL41 and 1,026 bp of the 3' flanking
sequence was excised from pN237 and inserted between the
EcoRI andPstI sites of the vectorpWR590-2 (20).
(iii) Plasmids used for hybridization probes. Plasmid pHcGAP contains a 1.2-kb cDNA fragment encoding a
por-tion of human glyceraldehyde-3-phosphate dehydrogenase (GAPD) (56). It was obtained from the American Type CultureCollection(Rockville, Md.). Plasmid pXlrll contains
a 4.6-kb fragment of Xenopus laevis rDNA inserted into the
EcoRI site ofcolicin El (11). The insert in pXlrll hybridizes with 28S rRNA.
Nucleic acid isolation. Plasmid DNAs were prepared by
CsCl density gradient centrifugation as described previously
MAP UNITS
0. .1 .2 .3 .4 .5 .6 .7 .8 .9 1.0
a b UL b a' c' ca
HindSII UL40 VHS(UL41) 489 a.a. UL42 Sal
0Sma Nru SmaSmaI3.779 kb
UL39 \ BamHI WMts70l
pHS
HindlIl SmaI ,. SmaI Sal
F- .--- <zz- zzAi- L"Fzzz --- - - -- pHS-ASma a.a.489--- 344 147---1
< 1463bp >
HindIII Sma Sma Sal
'-"-
--.-N,P/777--
pN237Pst Bam Hi EcoRI
Pst VHS(UL41) Eco RI LacZ
.--- pBK1
Hind III a.a.489----2391a.a.599 ---1 9a.a.
FIG. 1. Structures of plasmids containing wild-type and mutant vhs (UL41)genesand of aplasmid encoding aUL41-lacZfusionprotein. Beneath adiagramof the prototype orientation of the HSV-1 genome (lines 1 and 2) is an expanded view of the 3,779-bp HindIII-SalI fragment that spans map coordinates 0.592 to 0.614 on the HSV-1 genome(line 3)and is contained inpHS. The UL41(vhs)openreading frame is represented by a cross-hatched rectangle, and UL40 and UL42 are represented by open rectangles (36).The locations of the mRNAs for UL39, UL40, UL41, and UL42 are indicated by arrows (lines 3 and4) (1,18, 36,37).Short dashedlines indicate that the UL40 and UL42openreadingframes extend to the left of theHindlllsite and the right of the Sall site, respectively. The UL39 and UL40 mRNAs are 3' coterminal, with 5' termini located to the left of the HindIll site. The UL39 openreading frame is locatedentirelytothe left of theHindIll site. The portion of theHindIII-SalIfragment that rescuesthe temperature-sensitive mutation in ts701 (35) is shown in line 4. TheSmaIfragmentthat is deleted in pHS-ASmaand in mutant virus vhs-ASma is indicated in line 5 along with the predicted structure of the mutant vhs (UL41) polypeptide. The sizes (inbase pairs) of somesubfragments of theHindIII-SalI fragmentareshownin lines 6 to8. As is shown in line9,UL41 ofpN237 isinterrupted byinsertion,
at the NruI site, of an oligonucleotide that contains an EcoRI site (represented by an open box). To construct pBK1, theEcoRI-PstI fragmentfrompN237wasinserted between thecorrespondingsites in thepolylinkerofpWR590-2(line 10).Thepredictedstructureof the UL41-lacZ fusionprotein encodedbypBK1 is shownatthe bottom. a.a.,amino acids.
(40, 41).
Viral DNA for use in marker transferexperiments
was isolated essentially as described by Sandri-Goldin and coworkers (50). Total cytoplasmic RNA was isolated from infected and mock-infected cells as described
previously
(40,
41, 46).
Marker transfer. To transfer the pHS-ASma deletion into virus, pHS-ASmawas used to rescue a temperature-sensitive mutation inthe neighboringUL42 openreadingframethat is carried by ts701. Recombinant viruseswerethen screened
by
Southern blotting for cotransfer of the deletion in UL41. Briefly,Verocells(2 x
106/25-cm2
flask)weretransfected with 6p.g
of intact ts701 DNA, 2 ,ugofpHS-ASma that had been cleaved withHindlIl
andSalltoseparatethe insertandvector sequences, and 6p.g
of salmon sperm DNAessentially
as described by O'Hare and Hayward (39). The cultures were incubated at 34°C until a generalizedcytopathic
effect was J. VIROL.on November 9, 2019 by guest
http://jvi.asm.org/
[image:2.612.325.562.81.299.2]MULTIPLE v/is POLYPEPTIDES 7151 observed,atwhich pointthe cells werelysed bythreecyclesof
freezing and thawing and the progenyvirus was harvested in accordance with standard procedures (40, 41). The progeny viruswas plaquepurified twice at39°C.Isolated plaqueswere then picked, and the progeny was expanded into small virus stocks by infection ofVero cells at 34°C. A portion of each stock was frozen and saved, while infected-cell DNA was preparedfrom the remainder. Recombinant viruseswerethen screened by Southern blotting for cotransfer of thepHS-ASma deletion.Of10recombinants thatwerescreened,4 werefound tocontainthedeletion. One of thesewasplaquepurifiedonce more at 34°C, and the resultingmutant virus was designated vhs-ASma.
Southern and Northern (RNA) blot analyses. Methods for electrophoresis ofDNAand RNA, transfer of thenucleic acids toNytranmembranes, andhybridizationto32P-labeledprobes have been described previously (40, 41, 47). To analyze the structure of the vhs gene (UL41) of the recombinant virus, blots of viral DNA were probed with 32P-labeled pHS. To analyze the vhs-induced degradation of the host GAPD mRNA, Northern blots were probed with nick-translated pHcGAP, while 28S rRNA was detected with 32P-labeled pXlrll.
Analysis of infected-cell polypeptides (ICPs). Vero cells wereinfectedwith20 PFU percellandlabeled fortheintervals described in the text with either
[35S]methionine
or 32p. To label cells with[35S]methionine,
monolayers were washed twice with minimum essential medium (MEM) lacking methi-onine and overlaid with MEM containing 1/10 of the usual concentration of methionine and supplemented with 2% calf serum and 75pLCi
of[35S]methionine
per ml. Cells were labeled with32p;
by incubation in MEMlacking
sodium phosphateandsupplemented with 2% calfserumand 100pLCi
of
32p;
perml. At the end of thelabeling intervals,
cellswere scraped into ice-coldphosphate-buffered saline,
collectedby
centrifugation, and then either processed for
immunoprecipi-tationorlysed by boilingfor 10 min insodium
dodecyl
sulfate(SDS)
sample buffer (50 mM Tris[pH
7.0],
2%SDS,
10% glycerol, 5%P-mercaptoethanol).
Immunoprecipitates or whole-cell lysates were analyzed by SDS-polyacrylamide gel electrophoresis (PAGE) and autoradiography as described previously (29, 40).Virion purification. Wild-type, vhsl, andvhs-AvSma virions were collected from the extracellular medium of infected cultures and
purified
by sedimentationthrough gradients
of10 to 30% Dextran TIO(Sigma)
in MEMcontaining
0.5% (wt/vol) bovineserumalbumin (BSA),essentially asdescribed by Kousoulas et al.(28). Centrifugation
was done in a Beck-manSW41 Ti rotorfor 1h at29,000rpm.Fractionscontaining the virion peak were pooled and diluted with 2 volumes of MEM containing 0.5% BSA, and the virus was pelleted. Virions were resuspended in a small volume of SDS sample buffer, boiled for 10 min, and analyzed by SDS-PAGE and Westernblotting(immunoblotting) asdescribed below.Preparation of the UL41-lacZ fusion protein. The UL41-lacZfusion protein wasprepared from lysates of Escherichia coli containing
pBKI
bypreparative
SDS-PAGE that was followedby electroelutionfrom thegel
slices(21). Samples
of theproteinweredialyzed against
H20 overnight, lyophilyzed,
and resuspended in a small volume of
phosphate-buffered
saline.
Approximately
5 mg of the UL41-lacZ fusion protein wasroutinelyobtained from a500-ml culture of bacteria.Preparation of antisera. Polyclonal rabbit antisera were preparedagainst the
gel-purified
UL41-lacZfusionprotein
by standardprocedures (21).Immunoprecipitations. Infected Vero cells were labeled
from 4 to 20 h after infection with either
[355]methionine
or32p;. They
were then harvested andlysed
in either RIPA or SDSlysis
buffer. ForRIPAlysis,
cellsweresuspended
at 107/ml
in RIPA buffer (50 mM Tris
[pH 7.7],
150 mMNaCI,
1% NonidetP-40, 0.5% sodiumdeoxycholate,
0.1%SDS)
supple-mented with I mg of BSA per ml and protease and
phos-phatase inhibitors
(2
p.g
ofaprotinin
perml,
50pLg
ofphenyl-methylsulfonyl
fluorideperml,
1p.g
ofleupeptin
perml,
5mM EDTA, 50mM NaF, 0.2 mM sodiumorthovanadate,
30mM sodiumPPj)
(21, 57).
After30minonice,
thelysates
werespun for 1 h at40,000
rpm in a Beckman TLA 45 rotor, and the supernatants were stored at-90°C
forsubsequent
immuno-precipitation.
For SDSlysis,
cellpellets (approximately
107cells)
weresuspended
and then boiled for 10 min in 100Rl
of SDSlysis
buffer(50
mMTris[pH
7.5],
2%SDS)
supplemented
with theproteaseand
phosphatase
inhibitors described above. Thesamples
wereimmediately
diluted with 19 volumes of ice-cold RIPAbufferlacking
SDS and spun forI h at40,000
rpm in a BeckmanTLA 45 rotor, and the supernatants were
stored at -
90°C.
To initiate the immune
precipitations,
aliquots
of infected-celllysates
werebrought
to 1 mlby
addition ofRIPA buffer and incubated with 10 p.l of normal rabbit serum(Pierce
Chemical
Co.,
Rockford,
Ill.)
for 1 h at4°C.
ProteinA-Trisacryl
beads(200 pI.
ofa50%[vol/vol] suspension
inRIPAbuffer; Pierce)
wereadded,
andincubationwascontinued for1 h. Afterpelleting
of thebeads,
the supernatants were incu-bated for 1.5 hwith 5to 10 p.1 ofoneofthefollowing
sera:(i)
immune serum raised against the UL41-lacZ fusion
protein,
(ii) preimmune
serum, or(iii)
immune serum that had beenpreincubated
for I h with an excess ofgel-purified
fusionprotein.
A200-,ul
volume ofprotein
Abeadswasadded,
and incubation wascontinued for an additional 1.5 h. Thebeads werepelleted
andwashedfive times withRIPAbuffer,
and theprecipitated
proteins
were elutedby
boiling
the beads for 10 min in 100p1W
of 100 mM Tris[pH 7.0]-4%
SDS-20%glycerol-5%
No-mercaptoethanol.
Immunoprecipitated
pro-teins were
analyzed by
SDS-PAGE andautoradiography
asdescribed
previously
(29, 40, 45).
Western
blotting.
Proteins frompurified
virionsor infected-celllysates
wereseparated by
SDS-PAGE and transferred toHybond-ECL
nitrocellulose membranes(Amersham) by
stan-dard
procedures
(21).
The vhs(UL41)
polypeptides
weredetected
by
probing
the filters with immuneserumprepared
against
the UL41-lacZ fusionprotein. Complexes
of the vhs(UL41) protein
with theprimary antibody
werevisualized with ahorseradishperoxidase-conjugated secondary
antibody
(don-key
anti-rabbitimmunoglobulin
G;
Amersham)
and an ECL Westernblotting
detection kit(Amersham)
in accordance with the instructions ofthe manufacturer.RESULTS
To
identify
andcharacterize the vhs(UL41)
polypeptide,
weutilized a combination of genetic and
immunologic
ap-proaches. First,
we constructed a vhs mutantcontaining
adeletion of a substantial
portion
of the UL41 openreading
framewhich should encode a UL41
polypeptide
with alteredelectrophoretic mobility. Next,
we raisedpolyclonal
rabbit antiseraagainst
a UL41-lacZ fusionprotein containing
se-quencesshared
by
bothwild-type
andmutantformsofthe vhspolypeptide.
Thewild-type
and mutant forms of the vhspolypeptide
werethenidentifiedonthe basis oftwocriteria:(i)
specific reactivity
withthe antisera and(ii)
dependence
of the molecularmass of theprotein,
in apredictable
way, upon the vhs allele of theinfecting
virus.VOL.67, 1993
on November 9, 2019 by guest
http://jvi.asm.org/
7152 READ ET AL.
pHS VHS-,Srnm pHS-SLSma
Hindlil + + + + + + + + +
Sal Bam HI Sma
3779
2949
2313
1728
1463
+ + + + + + + + +
- + __ +-_-_+
_ + +
_-3191
E
D
. 6
1-j
w
LLJ
C) 5
Di1
of
0
5
10
1 2 3 4 5 6 7 8 9
FIG. 2. Southern blot of viral and plasmid DNAs. Plasmids pHS (lanes 1 to 3) and pHS-ASma (lanes 7 to 9) and viral DNA from
vhs-ASma (lanes 4 to 6)were cutwith the various combinations of HindIII,Sall,BamHI, and SmaI indicated. A plus sign indicates thata
DNAsamplewascutwithanenzyme,andaminussign indicates that it was not. The DNA fragments were resolved by electrophoresis throughanagarosegel, transferredtoNytran filters, and hybridizedto 32P-labeledpHS. The approximate sizes (in base pairs) ofsomeof the fragmentsare showntothe left andright of the autoradiogram.
Construction ofa vhs deletion mutant. Plasmid pHS
con-tains a3,779-bp HindlIl-Sall fragment containing UL41 from
wild-type HSV-1 (KOS) (Fig. 1). Examination of the nucle-otidesequenceindicates thatwild-type UL41 shouldencodea
vhs polypeptide of 489 amino acids (36). Plasmid pHS-z\Sma
wasconstructedby excisinga588-bp Smal fragment from the
middle of UL41 (Fig. 1). Mutant UL41 should encode a
293-amino-acid vhs polypeptide in which the first 147 amino acids of thewild-type proteinarefused in frametoaminoacids 344 through 489.
Tointroduce the deletion intoavirus, pHS-ASmawasused
torescue atemperature-sensitive mutationin theneighboring UL42 open reading frame, and viruses that grew at the nonpermissive temperature were screened by Southern blot-ting for cotransfer of the deletion in UL41. DNA from the mutantvirus, vhs-ASma, is comparedinFig.2toplasmids pHS and pHS-ASma. Cleavage of pHS with HindIll and Sall excised the insert from the vector, resulting in a vector
fragment of 2,949 bp anda3,779-bp insert containing wild-type
UL41 (Fig. 2, lane 1). In contrast, cleavageofvhs-ASmaviral DNA with the same two enzymes resulted in aHindlIl-Sall
fragment that had been shortened toapproximately 3,191 bp (Fig. 2, lane 6), the samesize asthe insert fragment thatwas
observedinplasmid pHS-ASma(Fig. 2, lane 9). A fragment of this sizewould bepredicted if the 588-bp SmaI fragment had been deleted from the middle ofthe vhsgene. SinceBamHI
cuts the wild-type vhs gene at asite 3 bp to the right of the left-hand SmaI site (Fig. 1) (36), restriction of pHS with BamHI in addition toHindlIl and Sall divided thewild-type
15 20 25 30 35
[image:4.612.337.551.68.316.2]HOURS POST INFECTION
FIG. 3. Single-step growth curvesforwild-typeHSV-1, vhsl, and vhs-ASma. Cultures of Vero cells were infected with 5 PFU of wild-type HSV-1 (0), vhsl (-),orvhs-ASma (A)percell. At various times after infection, the cells were disrupted by three cycles of freezing and thawing, and the virus concentration in the lysateswere
determinedby titrationonVero cells.
HindIII-SalI insert into two fragmentsof2,313 and 1,466 bp (Fig. 2, lane 2). Deletion of the 588-bp SmaI fragment from UL41 should eliminate this BamHI site. As predicted, the 3,191-bp HindIII-SalI fragment of vhs-ASma viral DNA was
resistant to BamHI (Fig. 2, lane 5), as was the HindIll-Sall
insert carriedby pHS-ASma (Fig. 2, lane 8). Cutting of pHS withSmaI in additiontoHindlIl andSall divided the wild-type HindIll-Sall insert into three fragments of 1,728, 1,463, and 588bp (Fig. 2,lane3).Asexpected, cutting of vhs-ASmaviral DNAor pHS-ASmawith the samethree enzymesresulted in bands of1,728 and 1,463 bp; however,no588-bpfragmentwas
observed (Fig. 2, lanes4and7).
Phenotypeof vhs-ASma.(i) Growth properties.Mutant vhsl exhibits a slight, but reproducible, growth deficit. Thus, vhsl produces smaller plaques than does the wild-type virus, has a
burst size that is reduced two- to fivefold, and is rapidly outgrownbythewild-typevirusuponrepeatedpassageof the
progenyfrom mixed infections(33, 45). To examinethe effect
of thevhs-ASmadeletionuponvirusgrowth,single-step growth
curves forwild-type HSV-1, vhsl, and vhs-ASma were
com-pared (Fig. 3). As was thecase for vhsl, the rise in titer of vhs-l\Sma wasdelayed somewhat relativeto that of the wild-typevirus; however, by24 hpostinfection, the yieldwasvery
similar.Thus,the vhs-ASma deletionhad, atmost,amarginal
effectupon virusgrowth in culture.
(ii) vhs activity. To analyze the virion host shutoff activityof vhs-ASma, Vero cellswereinfectedin thepresenceof 5 tigof dactinomycin per ml with either the wild-type virus of vhs-t\Sma and the decay of the cellular mRNA for GAPD was
analyzed by Northern blotting (Fig. 4). This cellular mRNA wasrelatively stableinmock-infectedcells(Fig. 4,lanes1to4) but decayed rapidly in cells infected with the wild-type virus (Fig. 4, lanes 5to8). GAPD mRNAwaseverybitasstable in
0-0
WILD TYPEA A VHS-ASMA
.... * VHS 1
[image:4.612.75.310.69.324.2]J. VIROL.
...
on November 9, 2019 by guest
http://jvi.asm.org/
MULTIPLE vhs POLYPEPTIDES 7153
MOCK WF VHIS-SMA
II MOCK WILD TYPE
10h 3h 5h 7h 10h 12h
MOC K VHS-ASMA
10r--- 5--7h---I___
l0h 3hl 5h 7h lOh 12h
1 2 3 4 5 6 7 8 9 10 11 12
FIG. 4. Comparison of the virion host shutoff activities of wild-type HSV-1(WT)andvhs-ASma.Verocells were mock infected (lanes1to 4) or infected with 50 PFU of wild-type HSV-1 (lanes 5 to 8) or vhs-ASma (lanes 9 to 12) per cell in the presence of 5 ,ug of dactinomycin per ml. Total cytoplasmic RNAs were prepared at 2 h (lanes 1, 5, and 9), 4 h (lanes 2, 6, and 10), 6 h (lanes 3, 7, and11),and 8 h(lanes 4, 8, and 12) after infection. After electrophoresis through an agarose gel and transfer to Nytran, the cellular mRNA encoding GAPD was detected with 32P-labeledpHcGAP.
cells infected with vhs-ASma as it was in mock-infected cells (Fig. 4, lanes1 to4and9 to12), indicating that vhs-ASma lacks detectable virion host shutoff activity.
(iii) Effectof thevhs-ASmadeletion upon viral gene expres-sion. Although the mutation carried by vhsl is not lethal, it does have asignificant effectuponthenormal cascade regula-tion of viralgeneexpression (29-31, 33, 40, 41, 45,55). Thus, in addition to being defective in virion host shutoff, vhsl produces viral mRNAsthataresignificantly more stable than those encoded by the wild-type virus (40, 41). The most obvious effect of this is that at latetimes, vhsl overproduces many immediate-early and early polypeptides (31, 40, 41, 45,
55).
Todetermine whether the vhs-ASma deletionhas asimilar effect
upon
viralgeneexpression,Verocellswerepulse-labeled with [3 S]methionine atvarious times after infection with the wild-type virusorvhs-zvSma
andthelabeled polypeptideswere examined by SDS-PAGE and autoradiography (Fig. 5). While inwild-type infections synthesis of immediate-early(ICPO) and early (ICP6, ICP8, ICP17, ICP36, and ICP41) polypeptides increased to peak rates at early times and subsequently de-clined, synthesis of these polypeptides continuedathigh levels for a prolonged period following infection with vhs-ASma. Thus, the effect upon viral gene expression ofthe vhs-ASma mutationwasindistinguishable from that previously reported forvhsl.(iv) Dominance relationships between
wild-type
HSV-1, vhs-ASma, and vhsl. Some HSV-1 strains that exhibit weak or slow virion host shutoff inhibit the shutoff activity of fast-shutoff strainsduring mixed infections (14, 23, 32). Of partic-ular interest is the report of Kwong and Frenkel that vhsl inhibits the shutoffactivity of wild-type HSV-1 (KOS) (32).To confirm this finding and to test the dominance relationship betweenvhs-ASma
and the wild-type virus, Vero cells were infectedin the presenceof dactinomycinwith various amounts ofwild-type HSV-1 (KOS) orwith mixtures containing differ-entratios of thewild-type virusandvhslorthewild-typevirus andvhs-ASma(Fig. 6). Totalcytoplasmic RNAs were prepared at 6 h after infection and analyzed by Northern blotting to detect the cellular mRNA for GAPD.Probing of thesameblot for 28S rRNA provided an internal control for the relative amountsof RNA loaded onto thedifferent lanesof thegel.Inaccord with earlier results (52,55), infection of cells with 20, 50,or100 PFUof thewild-type viruspercellresulted in the
6s
42 :
.22
''.''
92-.: .:~
....
7 . j 1 11_12;'
FIG. 5. Kinetics of viral gene expression by wild-typeHSV-1 and vhs-ASma. Vero cells were mock infected (lanes1 and 7) orinfected with 20 PFU of wild-typeHSV-1 (lanes 2 to 6) or vhs-ASma (lanes 8 to 12) per cell. The cultures were labeledwith [35S]methionine for 1-h intervals beginning at the postinfection times indicated above the lanes. At the end of the labeling intervals, whole-cell lysates were prepared and the labeled polypeptides were analyzed by SDS-PAGE andautoradiography. ICPs are labeled to theright of lanes 6 and 12. ThefollowingICPs aretheproducts of the indicated viral open reading frames: ICP5
(UL19),
ICP6(UL39),
ICP8(UL29),
ICP25(UL48),
ICP29(US3),andICP36(UL23) (12,48).Scales of molecularmasses areshowntotheleft of lanes1 and7. The dotstothe rightof lanes1 and 7 indicate selected cellular polypeptides for which secondary shutoff of host protein synthesis (45)wasparticularly evident in the vhs-ASma infections.
degradation of all detectable GAPDmRNA(Fig. 6, lanes2 to 4). Similarly, efficient
degradation
of GAPD mRNA was observed when cells were coinfected with 80 PFU of the wild-type viruspercelland 20 PFU of vhslpercell(Fig. 6, lane 5). However, infection withamixturecontaining50 PFUof the wild-type viruspercell and 50PFUof vhslpercell resulted in significantly lessdegradation
of GAPDmRNAthan did infec-tion with50 or 100 PFU of thewild-type virus alone percell (Fig. 6, lane 6).In contrast,coinfection of cellswith 50PFUof wild-type HSV-1 per cell and 50 PFU ofvhs-ASma per cell resulted in efficient vhs-induced degradation of host mRNAs(Fig.
6, lane 8). Thus, while both the vhsl and vhs-ASma mutations abolished virion host shutoffactivity, the vhsl allele wascodominant with the wildtypeinamixed infection and the vhs-ASma allele was recessive.Identificationofmultipleforms ofthevhs (UL41) polypep-tide. (i) Production of antisera. To identify the vhs polypep-tide, polyclonal antisera were raised against a bacterially expressed UL41-lacZ fusion
protein
and used inimmunopre-cipitation
and Westernblotting
experiments to characterize theproteins
encodedby wild-type
HSV-1 and mutants vhs-ASma and vhsl. On the basis of its DNA sequence, pBK1 should encodeafusionprotein
containing
the first 599 amino acids ofP-galactosidase,
followedby
the nine-amino-acid(GRARIQLSF) peptide
encoded by linker sequences frompWR590-2
andpN237,andaminoacids 239through
489 of the vhs polypeptide from HSV-1 (KOS)(Fig. 1).
In accordwith thisprediction,thepBK1
fusionprotein
exhibitedanapparent molecular mass on SDS-PAGE ofapproximately
100 kDa(data
notshown).(ii) Immunoprecipitation of the vhs polypeptide from in-fected cells.The antiserawerefirst usedto
immunoprecipitate
35S-labeled
proteins
fromextractsof infectedormock-infectedVOL.67, 1993
on November 9, 2019 by guest
http://jvi.asm.org/
[image:5.612.67.279.80.186.2] [image:5.612.316.549.85.243.2]7154 READ ET AL.
1 2 3 4 5 6 7 8
28S
rRNACO)
0
I~-Mock
ASma WT
E
E
E
E
Or
EE
or
E
E
~
EjE._ C&_-._
- 100 50 20 80 50 20 50
- - - - 20 50 80
-- - - - 50
FIG. 6. Dominance relationships between vhs mutants and wild-type HSV-1 (WT). Vero cellswere mock infected orinfected with various combinations of wild-type HSV-1, vhsl,orvhs-ASma, all in the presenceof 5 p.gof dactinomycinperml. The number of PFU of each
viruspercell isindicated below each lane. All cultureswereharvested at 6 h after infection. Whole cytoplasmic RNAswere prepared and
analyzed by Northern blottingto detect the cellular mRNA encoding GAPD, aswellas28S rRNA.
cells lysed in RIPA buffer (Fig. 7 and 8, lanes 1 to 3). The
immune serum precipitated a 58-kDa polypeptide from cells
infected with wild-type HSV-1 (indicated by closed circles to
the right of Fig. 7, lane 7, andtothe leftofFig. 8, lane 3). The
apparent molecular mass of this protein was in close
agree-ment with the value of 55 kDa predicted for the wild-type UL41 polypeptide from the HSV-1 nucleotide sequence (36)
and identical to that reported by Wagner and coworkers for the invitrotranslation product of mRNA mappingtowhat is
nowknowntobeUL41(1, 18). As would be predicted if itwere aproduct of wild-type UL41, the 58-kDa polypeptidewas not
detectedinextractsof cells infected withvhs-AvSma; instead,a
31-kDapolypeptidewasprecipitated(indicated byanarrowto
theleft ofFig. 7, lane 5). As expected, theapparent molecular
mass of 31 kDa was very similar to the value of 33 kDa predicted from the DNAsequence.Neither the 58-kDanorthe
31-kDa protein was precipitated by preimmune serum from infected-cell lysates (Fig. 7, lanes4and6; Fig. 8, lane 2) orby
immuneserumfrom lysatesof mock-infected cells(Fig. 7, lane 3). In addition, preincubation of the immune serum with an excessof the unlabeledUL41-lacZ fusion protein significantly reduced the amount of the labeled 58-kDa polypeptide that could besubsequently precipitated from wild-type infected-cell lysates (Fig. 8, lane 1). This combination of immunologic and genetic results identified the 58- and 31-kDa polypeptides as
products of the vhs genes (UL41) of wild-type HSV-1 and
vhs-\Sma, respectively.
Interestingly, the immune serum precipitated significantly
less of the 31-kDa polypeptide from cells infected with vhs-zvSmathan it did of the wild-type 58-kDa polypeptide. Thiscan
beseenin Fig. 7, wherealonger autoradiographicexposure is
shown for immunoprecipitates from mock-infected and vhs-ASma-infected cells (Fig. 7, lanes 2 to5) than for those from cells infected with the wild-type virus (Fig. 7, lanes 6 and 7).
VP5
-VP7/8
-VP1 5
-VP16
-VP19C
-.. b
-150
65 ... ,
a".
- 50A
- 38
- 33
VP23 - *
[image:6.612.69.302.77.293.2]1
2
3
4
5
6 7
FIG. 7. Immunoprecipitation of the vhs (UL41) protein from
RIPA lysatesofinfected cells. Vero cellswerelabeled with
[35S]me-thionine from 4 to 20 h after infection withwild-type (WT) HSV-1
(lanes6and 7)orvhs-ASma (lanes 4and5)orafter mock infection
(lanes 2 and 3). Lysateswereprepared in RIPA buffer, and
immuno-precipitateswereprepared by using either immune (lanes 3, 5, and 7)
or preimmune (lanes 2, 4, and 6) sera. The 58-kDa vhs (UL41) polypeptide thatwas present in immuneprecipitates from wild-type
lysates isindicatedby the closed circle tothe right of lane 7. The
65-and 43-kDapolypeptides that coprecipitated with the vhs polypeptide
are indicated by the open and closed triangles, respectively. The 31-kDa vhs(UL41) polypeptide encoded by vhs-ASmaisindicatedby the arrowheadtothe left of lane 5. Totalproteins containedinpurified wild-type HSV-1 virions are shown in lane 1. The designations of selected virion polypeptides are shown to the left of lane 1. The molecular masses (in kilodaltons) of virion proteins VP5 (UL19),
VP16(UL48), VP19C (UL38), VP22 (UL49), and VP23(UL18) are
shown inthe scaletotheright of lane 7. The asterisktothe left oflane indicatesaminorvirionpolypeptide that comigrated with the 43-kDa polypeptide that coprecipitatedwith thevhspolypeptidefrominfected
cell lysates.
4*
GAPD mRNA
Mock
VHS I
Vhs-ASma
J. VIIcOL.
on November 9, 2019 by guest
http://jvi.asm.org/
[image:6.612.329.559.88.526.2]MULTIPLE v/Is POLYPEPTIDES 7155
RIPA Lysis
SDS
Lysis
Wild
Type
WildType
Vhs 1a)
E .E E
EE
a) a) > a) a)
SO C a)fDC'
O*
EE
mH
E EE
a.E
E i a a.150
-a.
65 -I ,,4P
.0
50
-- )I
33
[image:7.612.55.291.75.400.2]-1 2 3 4 5 6 7 8 9 10
FIG. 8. Immunoprecipitation of vhs (UL41) pi
infected cellslysedinRIPAorSDSlysisbuffer. Vero(
with
["3S]methionine
from 4 to 20 h after infectio HSV-1 (lanes 1 to3 and 5 to 7), /hsl (lanes 8to I(lanes11 to13). Infectedcellswerelysedineither R
1 to3)orby boiling in SDSlysisbuffer(lanes5 to
cipitates were prepared with immune serum (lanes
preimmune serum (lanes 2, 6, 9,and 12),orimmunl been preincubated for I h with an excess of the
protein (lanes 1, 5, 10, and 13). The two forms of
polypeptide immunoprecipitated from SDS lysates with thewild-typevirusareindicatedbythe closedar
the left of lane 7,while the 58-kDa vhs polypeptide tated from RIPAlysates isindicatedbythe closed ci lane 3. The two forms of the vhs (UL41) protein lysates of v/isl-infected cells are indicated by the a
squaretotherightoflane8,while the 31-kDa vhs
pol)
byvhs-ASma is indicatedbythe arrowheadtothe left proteins contained in purified wild-type HSV-1 virii lane4,and 65-kDa virionpolypeptide VP16(UL48) linetotherightof lane 4. A scale of molecularmasseis showntothe leftoflane 1. Thedouble arrowhead5 and 3 indicate the 65- and 43-kDa polypeptides th with the vhspolypeptidefrom RIPAlysatesof infec
Thus, background bands that arebarelyvisible 7are readilyapparent inlanes 2through 5. Re of the 31-kDa polypeptide were precipitatec controlexperimentsindicated that an excessof
had beenused in the immunoprecipitations (d; Reduced amountsof themutantvhs (UL41)p
were observed by immunoblotting ICPs follov by SDS-PAGE, aswellasby immunoprecipitat cell lysates that had been previously denature
SDS
(Fig. 8;
seeFig. 9).
Whether the reduced abundance of the vhs-ASma polypeptide was due to a decreased rate ofVhs-ASma synthesis or more rapid turnover of the protein is under
Vhs- ASma investigation.
Inadditiontothe 58-kDa
wild-type
vhs(UL41)
polypeptide,
the immune serum
precipitated
several labeledpolypeptides
:3 thatcomigratedwith structuralpolypeptidesofpurified HSV-1 EE virions (Fig. 7, compare lanes 1 and 7; Fig. 8, compare lanes 3
-n
and4). Reproducibly,
the mostprominent
of these were a65-kDa
polypeptide
thatcomigrated
with viriontranscriptional
a) : ct transactivator
VP16
(UL48)
and a 43-kDapolypeptide
thatCE
comigrated
with a minor virion component. Neither the 65-E a) a) kDanor the 43-kDapolypeptide
wasprecipitated by
immune E X m serumfromlysates
ofmock-infected cells(Fig.
7, lane3)
orby
preimmune
serumfromlysates
ofcells infected withwild-type
HSV-1 or vhs-ASma
(Fig. 7,
lanes 4 and6;
Fig.
8,
lane2).
However, it is of the most
significance
for the presentstudy
that small amounts of both the 65- and 43-kDa
polypeptides
were
precipitated by
immune serum fromlysates
of cells infected with vhs-ASma(Fig.
7, lane5), indicating
thatthey
were not
products
ofUL41. Inaddition, partial
V8proteolysis
of the58-and 65-kDa
proteins immunoprecipitated
from cells infected with thewild-type
virus resulted in very different patterns ofdigestion, providing
further evidence that the 65-kDapolypeptide
was notencodedby
UL41(43).
Inadditiontothe 58-and 31-kDa versions of thevhs
(UL41)
AOI
polypeptide
and the 65- and43-kDaproteins,
allofwhichwereprecipitated by
immune but notpreimmune
serum,proteins
forming
a broad bandranging
from 75 to 90 kDa werenonspecifically precipitated
from infected-celllysates by
im-mune,preimmune,
orpreadsorbed
immune serum(Fig. 7,
lanes 6 and
7;
Fig.
8, lanes I to3).
Theseproteins
wereS11 12 13 observed only when a source of serum was included in the olypeptides from
precipitation
reaction,ruling
out thepossibility
thatthey
cells were labeled interacted
directly
with theprotein
Abeads(data
notshown).
in with wild-type The intensity of the band was dependent upon the extent to 10), orvhs-ASma which the lysates had been precleared by incubation with IPAbuffer(lanes normal rabbit serum and protein A beads prior to initiation of
13). Immunopre-
theimmuneprecipitation.
HSV-1glycoproteins
gE
andgI
havee serum that had been shown to form a complex that hasFcreceptor activity (3, JL41-/acZ fusion 24, 25). In view of this, it is likely that the band of nonspecifi-f the vh/s (UL41) cally
precipitated
proteins was due to viral glycoproteins of cells infectedprecipitated
becausethey
bound to the Fcdomains of immu-ndopencircles tonoglobulin
G molecules thatsimultaneously
interacted withi
immunoprecipi- the protein A beads.
ircleto the left of (iii) An additional form of the vhs polypeptide identified by observed in SDS immunoprecipitation and immunoblotting of denatured sterisk and open polypeptides. Since the immune serum was raised against
ypeptide
encodedsamples
of theUL41-lacZ
fusionprotein
that had beentos
are shown in denatured and purified by SDS-PAGE, it was of interest toiis indicatedbya determine whether it would recognize the authentic vhs s(in kilodaltons)
polypeptide following
denaturation. This was tested in twosbetween lanes 2 ways.
(i)
Infected cellswerelysed by boiling
in 2%SDS,
after at coprecipitated which the lysates were chilled and diluted with 20 volumes of ted cells. RIPA buffer lacking SDS, and the vhs (UL41) polypeptide wasimmunoprecipitated (Fig. 8,
lanes5through 13).
(ii) Following
lysis
ofthe cellsby boiling
in 2% SDS and 5%3-mercapto-in lanes 6and ethanol,the ICPswere resolved
by
SDS-PAGE andanalyzed
ducedamounts
by
Westernblotting
(Fig. 9).
i,
eventhough
Theimmuneserumprecipitated
a58-kDapolypeptide
from immuneserum SDSlysates
of cells infected withwild-type
HSV-1(Fig. 8,
ata not
shown).
closed circle to the left of lane7)
thatcomigrated
with the)olypeptide
also 58-kDa vhspolypeptide
precipitated
from RIPAlysates (Fig. 8,
ving separation
closed circletotheleftof lane3).
Inaddition, denaturation of :ionof infected- the ICPsprior
toimmunoprecipitation virtually
abolished dby
boiling
incoprecipitation
of the 65- and 43-kDapolypeptides
(Fig. 8,
Vol.. 67, 1993
on November 9, 2019 by guest
http://jvi.asm.org/
7156 READ ET AL.
B
E
C,)
o
.
c0 en u)
-o
Q:
C/)-c
A
Cell Lysate Virions
CZ CZ
a E a E
o Co a Co
v >
V~
<<)nU
80--_u
47-33
-24
-IF'
S..) 47
-33
-
24-1
2
3
FIG. 9. Western blot analysis of vhs (UL41) polypeptides. Vero cellswereinfected with20PFU of wild-type HSV-1 (panel B, lane 1), vhsl (panelA,lane2,andpanel B, lane 2),orvhs-ASma (panelA,lane 3)permlor weremockinfected(panel A,lane1). The cellswerelysed
at20 h afterinfectionormockinfectionby boilinginSDSlysis buffer. Proteins were resolved by SDS-PAGE and analyzed by Western
blotting with antiserum prepared against the UL41-lacZ fusion pro-tein. A scaleof molecularmasses(in kilodaltons)is showntothe left of lane 1.
comparelanes3 and7),afindingconsistentwith thepossibility that the 65- and 43-kDapolypeptideswerecoprecipitated with
the vhs protein from RIPA lysates because they formed a
physical complex with it. Surprisingly, although the 58-kDa polypeptide was the major protein precipitated from SDS
lysates of infected cells, the immune serumalso precipitated anotherpolypeptide with an apparent molecular massof 59.5 kDa (Fig. 8, opencircle to the left oflane 7). Densitometric scanning of appropriate exposures of this gel and others indicated that the band formed bythe 59.5-kDa polypeptide
was at least threefold less intense than that of the 58-kDa protein. Similar resultswereobtainedbyWestern blotanalysis
of ICPs (Fig. 9); namely, a doublet consisting of a major
58-kDa polypeptide andaless abundant 59.5-kDaproteinwas
detected in extracts ofcells infectedwith thewild-type virus, while the65- and 43-kDapolypeptideswere not.The58- and 59.5-kDapolypeptideswerebothjudgedtobeproducts of the UL41 open reading frame on the basis of three findings. (i)
Neither polypeptide was precipitated by preimmune serum
frominfected-cellextracts (Fig. 8, lane 6)ordetectedwith the
immuneserum used toprobe immunoblots of mock-infected-celllysates (Fig. 9A, lane 1; Fig. 1OA, lane 1). (ii) Preincuba-tion of the immuneserum with an excess of thepBKI fusion
protein completely abolished subsequentimmunoprecipitation of both the58- and59.5-kDaproteins from lysates of infected cells(Fig. 8, lane 5). (iii) Neitherpolypeptide wasdetectedby
immunoprecipitation (Fig. 8, lane 11)orimmunoblotting(Fig.
9A, lane 3) inextractsofcells infected withvhs-A1Sma. Instead, in thiscase, weobserveda31 -kDapolypeptide (Fig. 8, lane 11;
1 2 3 4 5 1 2 3
FIG. 10. Comparison of vhs(UL41) polypeptidesin infectedcells and virions. (A) Whole-cell lysates from mock-infected (lane 1), wild-type HSV-1-infected (lane 2), and vhs-ASma-infected (lane 3) Verocellswereanalyzed by SDS-PAGE and Western blotting along-sidewild-type (lane 4) and vhs-ASma (lane 5)virions.Thetwoforms of the wild-type protein that were present in infected cells are
indicatedby the closed andopencirclestothe left of lane 2,while the single form thatwasincorporated into wild-type virions is indicated by
theclosed circletotheleftoflane4.The form of thevhspolypeptide
thatwaspresent incells infected with vhs-ASmabutnotincorporated
intovirions is shownby the arrowheadtothe left oflane3.Ascaleof molecular masses(in kilodaltons) is shown tothe left of lane 1. (B) Western blot analysis ofa whole-cell lysate from vhsl-infected cells (lane 1), wild-type virions (lane 2), and vhslvirions(lane 3).Theopen squareand asterisktotherightof lane1indicatethetwoforms of the
vhs polypeptide that were present in cells infected with vhsl; the asteriskto the leftof lane 3indicatesthe vhs polypeptide presentin vhslvirions.
Fig. 9A, lane 3) whose detection could be abolished by preincubation of the immune serum with the fusion protein (Fig. 8, lane 12). Therefore, the wild-type 59.5-kDa polypep-tide represents anadditional form of the vhs (UL41) protein
thatwasdetected by the immune serum only following dena-turation.
Two vhs (UL41) polypeptides were also observed in cells infected with mutantvhsl (Fig. 8, lane 8; Fig. 9A, lane2; Fig. 9B, lane 2; Fig. lOB, lane 1). However, the polypeptides encodedby vhsl differed from their wild-type counterparts in two important respects. (i) The two vhsl polypeptides exhib-itedalteredmobilitiesonSDS-PAGE, migrating withapparent molecular massesof 57 and 59 kDaasopposedto58 and 59.5 kDa for the wild-type polypeptides. (ii) While the 59.5-kDa form of the wild-type vhs polypeptide was significantly less abundant than the58-kDaform, the 57- and59-kDa polypep-tides encoded by vhsl were approximately equally abundant. Thefact that theelectrophoretic mobilitiesandrelative
abun-A
80
-
4-C)Z o
>a
a .0
a) m
B
U,
0
-c0
1
2
J.VIROL.
on November 9, 2019 by guest
http://jvi.asm.org/
[image:8.612.68.302.74.328.2] [image:8.612.326.561.78.359.2]MULTIPLE vhs POLYPEPTIDES 7157 dances of thepolypeptidesweredependentuponthe vhs allele
of the infecting virus provides further evidence that for both the wild-type virus and vhsl, the two
proteins
were both products of UL41.Structural polypeptides of wild-type and mutant virions. Thefindingthat two formsof the vhs polypeptidewere present in cells infected with wild-type HSV-1 or vhsl raised the question of whether both forms ofthe proteinwere
incorpo-rated into virions, as well as whether the shortened 31-kDa polypeptide encoded by vhs-ASmawas
packaged
into thevirus. To answer these questions, thepolypeptides
ofpurified
wild-type, vhsl, and vhs-ASma virions werecompared by
SDS-PAGE and immunoblotting to theproteins
present inlysates
of whole infected cells.
The results shown in Fig. 10 allowedtwo important conclu-sions. (i) Although two forms of the vhs
(UL41)
polypeptide
were present in cells infected with the wild-type virus
(Fig.
1OA, lane 2) or vhsl (Fig.
lOB,
lane 1),only
the faster migrating formwasincorporated
into virions(Fig.
IOA,
lane4;
Fig.
1OB,
lanes 2 and 3). (ii) While the 58-kDawild-type
and 57-kDa vhslpolypeptides
wereeasily
detectedwithin virions (Fig. 10A, lane4),
the 31-kDaprotein
encodedby
vhs-ASma was not (Fig.1OA,
lane5).To ensure thatthe latter resultwas not simply due tounequal loading
of thegel,
we utilized35S-labeled
virions andanalyzed
the filterby
autoradiography
to obtain
profiles
of total virionpolypeptides.
Comparison
of thewild-type
andvhs-ASma virions immunoblotted inFig.
1OA revealed similar intensities for structuralproteins
other than vhs (data not shown),indicating
thatapproximately
equal
numbersofwild-type and mutantvirionshadbeen loadedonto
the gel and transferred to the nitrocellulose.
Thus,
although
the 31-kDa
protein
encodedby
vhs-ASmawas present within infected cells, it was notpackaged into virions.Alternate forms of the vhs polypeptide differintheextentof phosphorylation. Smibert and coworkers have
reported
that a58-kDa
polypeptide
that reactswith antiserum raisedagainst
asynthetic
peptide
from UL41 isphosphorylated (54).
Since numerousproteins
havebeen showntoexist in alternate forms that differ in the state ofphosphorylation
(6-8,
27,
57),
weundertook to determine
(i)
whether both forms of the wild-type and vhslpolypeptides
werephosphorylated
and(ii)
ifso, whetherthey differed inthe extent ofphosphorylation.
Cells infected with
wild-type
HSV-1 or vhsl were labeledwith
[35S]methionine
or32Pi
andlysed by
boiling
inSDS,
andimmunoprecipitates
wereprepared
andanalyzed
as described above. The results shown inFig.
11 allowed twoimportant
conclusions.
(i)
Both forms of thewild-type
and vhsl UL41polypeptides
werephosphorylated (Fig. 11,
lanes 3 and7).
(ii)
The relative intensities of the bands formed
by
the twowild-type and the two vhsl
polypeptides
depended
upon whether the cells had been labeled with35S
or32p. Thus,
densitometric
scanning
of theautoradiogram
revealed that for[35S]methionine-labeled immunoprecipitates,
thebandformedby
the 59.5-kDawild-type
polypeptide
was at least threefold less intense than that of the 58-kDa virion-associated form (Fig. 11, lane2).
In contrast,analysis
of32P-labeled
immuno-precipitates indicated that the twowild-type
bands were ap-proximatelyequally
intense(Fig. 11,
lane3).
Aqualitatively
similar result was observed for the two UL41
polypeptides
encodedby vhsl.While the intensitiesfor the two
35S-labeled
polypeptides were
approximately
equal,
the band formedby
themore
slowly
migrating 32P-labeled
polypeptide
was approx-imately five timesmore intensethan that of the faster 57-kDa form.Therefore,
for both thewild-type
virus andvhsl,
the moreslowlymigrating
vhs(UL41)
polypeptide
was morehighly
Wild
Type
Vhs 1
I II - --.I
35-S
32-P
35-S
32-P
mIm
m
m
a) a) C)
E c
clE
E cD D E E
a) O a)O
CL- L- CL-L
1
23
4a)
D
U)
C E
D E
E
5
6
78
FIG. 11. Alternate forms of the vhs
(UL41)
polypeptide
differ intheextentof
phosphorylation.
Verocellswereinfected with 20 PFU ofwild-typeHSV-1
(lanes
I to4)
orvhsl(lanes
5to8)
percell. The cellswere labeled from4 to20 h
postinfection
with either[35S]methionine
(lanes 1, 2, 5, and6)
or32P;
(lanes 3,4, 7, and8)
and thenlysed by
boiling
in SDSlysis
buffer. Immune andpreimmune
precipitates
wereprepared
andanalyzed by
SDS-PAGE andautoradiography.
Thetwoforms of the
wild-type
vhs(UL41)
polypeptide
are indicatedby
the closed and open circlesto the left of lane 2 and theright
of lane3, while thetwoUL41polypeptides produced by
vhslareindicatedby
the asterisk and open boxtothe left of lane 6and theright
of lane 7.phosphorylated
than the fastermigrating
virion-associated form.DISCUSSION
The
primary
contributions ofthiswork are the isolation ofan HSV-1 mutant
containing
a deletion in theUL41
openreading
frame and the identification ofmultiple
forms of the vhs(UL41)
polypeptide.
In a recentstudy,
Smibert and coworkers identified a 58-kDapolypeptide
within HSV-1-infected cells and virions that reacted with antiserum raisedagainst
asynthetic
peptide
corresponding
to amino acids 333through
347 of UL41(54).
Thepresent
study
confirms this result and extends it in severalimportant
respects.
Most
significantly,
whereasSmibertand coworkersobserveda
single
vhs(UL41)
polypeptide,
we identified twoelectro-phoretically
distinguishable
forms oftheprotein
in cells in-fected witheitherwild-type
HSV-1 ormutantvhsl. Character-ization of the alternative vhs(UL41)
polypeptides
indicated thatthey
differed in severalimportant
ways.(i)
For both the VOL.67, 1993*08
0on November 9, 2019 by guest
http://jvi.asm.org/
[image:9.612.360.497.77.403.2]7158 READ ET AL.
wild-type virus and vhsl, the two forms of the protein were phosphorylated to different extents. (ii) Although both were present within infected cells, only the faster migrating, less phosphorylated form was incorporated into virions. (iii) The
twowild-type polypeptides couldbedistinguished with regard to the conditions under which they were reactive with anti-serumraised against aUL41-lacZ fusion protein.
Thefinding that only the faster migrating, less phosphory-lated form of the vhs (UL41) polypeptide was incorporated
intovirionssuggeststhatposttranslational processing (possibly involving regulated phosphorylation and/or dephosphoryla-tion) is important in one or more steps of the pathway involving de novo synthesis of the protein, its subsequent
transport to the nucleus, and eventual incorporation into
progenyvirions. Ifthis is the case,the altered ratio of thetwo
forms produced by vhsl may reflect the accumulation of an inefficiently processed precursor at some step in the pathway. Oneshould emphasizethatwhile thedata indicatethat thetwo
wild-type andtwo vhsl polypeptides differ with respect to the extentofphosphorylation, itis unclearwhetherthis is theonly differencebetweenthem. Forexample,onecannotexcludethe possibility that the wild-type 58-kDa polypeptide is derived from the 59.5-kDa form by proteolytic removal of a small phosphorylated peptidefromone endof the molecule. Sucha cleavagewouldgive risetoafaster migrating, less
phosphory-lated formof theprotein,which isconsistentwith the data. In view of the fact that proteolytic processing of other HSV polypeptides has been observed coincident with the assembly ofcapsids (34), thispossibility isworthy ofinvestigation.
Interestingly, the two forms of the wild-type vhs (UL41) polypeptide could be distinguishedwith regard to immunore-activity. While the 58-kDa polypeptide was efficiently
immu-noprecipitatedfromcelllysatesprepared eitherin RIPAbuffer
or by boiling cells in SDS, the 59.5-kDa polypeptide was precipitated only followingdenaturation.Thisdifferencecould reflect differences in the conformation of the proteins, their
state ofposttranslational modification, or their state of mul-timerization orassociationwith otherpolypeptides.For
exam-ple,inRIPAbuffer,the59.5-kDa formof theproteinmayexist as amultimeror aspartofacomplexwith otherpolypeptides,
the result of which is to mask epitopes so that they are not
available forantibody binding. Disruption of the multimersor complexes by boiling in SDS would render the epitopes accessible toantibodiesand allowimmunoprecipitation of the protein. Alternatively, even if it exists as a monomer, in its native form, the 59.5-kDa polypeptide may lack all epitopes
that are recognized on the 58-kDa protein. Denaturation of
the protein by boiling in SDS might expose denaturation-specific epitopes that arerecognized by antibodiespresent in the immune serum. Whether these differences in
immunore-activity of the 58- and 59.5-kDa polypeptidesreflect function-ally important differences in their structures or states of aggregation remainstobe determined.
Characterizationofvhs-ASmarevealed that itwassimilarto
vhsl in many respects. Both viruses lacked any detectable
virionhostshutoffactivity,andbothcarried mutations that had similareffectsuponviralgeneexpression.Themajordifference
was that vhsl was codominant with the wild-type virus in a
mixedinfection, while vhs-ASmawasrecessive. This difference could be explained by the absence of the vhs-ASma protein from mutant virions. The fact that the UL41 polypeptide encoded byvhs-ASma was not packaged even though it was presentwithininfectedcellssuggeststhat iteither is misfolded
orlacksadomainrequiredfortransport to the nucleusorfor packaging into virions. Studies are underway to define any
nuclear localization or packaging signals by site-directed mu-tagenesis.
Mutants encoding UL41 polypeptides that are not
packaged
should fall into two groups: those for which themutant
protein
would be able to induce mRNA degradation, if it was present, and those for which themutantprotein lacks
mRNA-degrada-tive activity. Preliminary data suggest that
vhs-AiSma
falls into the latter category.Cotransfection of cells with a reporter gene encoding chloramphenicol acetyltransferase(CAT) anda wild-type vhs gene resultsin significantly less CAT activity than does cotransfection with the CAT gene and a control plasmidfrom which the vhs gene has beendeleted,
presumably because expression of the vhs polypeptide causes destabilization of CAT mRNA (42). However, cotransfection of cells with the CAT gene and a plasmid containing the vhs-ASma mutation results in production of just as much CAT activity as does cotransfection with the CAT gene and the controlplasmid.In the future, it will be important to distinguish mutations that affect packaging of the vhs polypeptide from those that affect itsmRNA-degradative activity.The findings that vhsl is codominant in a mixed infection and that some slow-shutoff strains of HSV inhibit the host shutoff activity of other fast-shutoff strains (14, 23, 32) have important implications with regard to the mechanism of vhs action, suggesting that the vhs protein is multimeric or that it interacts with cellular proteins that are present in limiting amounts. Recent studies of the native vhs polypeptide by velocity sedimentation and gel filtration indicate that it has an apparent molecular mass of approximately 120 kDa; this finding is consistent with either of thesepossibilities (26).
Ofpotential importance was the finding that in RIPA buffer, the 58-kDa vhs polypeptide was immunoprecipitated along with the 65- and 43-kDa polypeptides that comigrated on SDS-PAGEwith major tegument protein VP16 and another minor virion polypeptide. The identities of these coprecipi-tatedproteins remain to be definitively determined. However, the factsthat they were labeled with[35S]methionine during an intervalwhen, in wild-type infections, there was little ongoing host protein synthesis and that they comigrated with two knownvirion structural proteins suggest that they were, infact, virusencoded. Coprecipitation of the 65- and 43-kDa polypep-tides with the vhs (UL41) protein could have resulted from several alternative mechanisms: (i) nonspecific sticking of the proteins to immune complexes or protein A beads; (ii) specific recognition of theproteins by antibodies in the immune serum, or(iii) coprecipitation of the proteins with the vhs polypeptide because they formed a stable complex with it. The fact that neither the 65-kDanor the 43-kDa protein was precipitated by preimmune serumargues against the first possibility. Although it is notpossible to rule out either of the last two alternatives, severalconsiderations favor the third. (i) Reduced amounts of the 65- and 43-kDa polypeptides were precipitated from cells infected with vhs-ASma, paralleling the reduced amounts of the mutant vhs polypeptide that were detected. (ii) The 65-kDa, 43-kDa, and vhs polypeptides were not immunopre-cipitatedfrom lysates of cells infected with a nonsense mutant encoding a vhs polypeptide consisting of the first 237 amino acids ofUL41 (42). This result was expected for the mutant vhs polypeptide, since it lacked sequences in common with the UL41-lacZ fusion protein against which the immune serum was prepared. However, the absence of the 65- and 43-kDa polypeptides from immune precipitates from cells infected with thenonsense mutant and the reduced amounts that were precipitated from cells infected with vhs-ASma are difficult to explain if the 65- and 43-kDa polypeptides reacted directly with antibodies in the immune serum. Smibert et al. have J. VIROL.
on November 9, 2019 by guest
http://jvi.asm.org/
MULTIPLE vhs POLYPEPTIDES 7159
recently reported that the 58-kDa vhs (UL41)
polypeptide
forms a specific complex with VP16 (UL48) in vitro (53), strongly suggesting that the 65-kDaprotein thatcoprecipitated withthe vhs polypeptide in ourstudieswas,in fact, VP16.
Two ofthemostimportantquestions raised by this studyare how many forms of the vhs protein are there, and what are their functions? Whiletwoformsof theproteinwereidentified byone-dimensionalSDS-PAGE, it ispossible, ifnotlikely, that additional forms will be resolved by electrophoresis on two-dimensional gels. Our finding that only the faster migrating, lessphosphorylated polypeptidewasincorporated into virions revealed one important functional difference between the alternative forms of the protein. Another may involve their relative abilitiestoinducemRNAdegradation. The vhs protein has been shown to accelerate degradation of both host and viral mRNAs nonspecifically (30, 40, 41, 52, 55). As such, a smallamountoftheproteinapparently isbeneficialtothevirus because itfacilitates host shutoff and the
sequential
transition between expressions of different classes of viral genes. How-ever,in view of its lack ofspecificity,
denovosynthesis
oflarge amounts of the vhs protein might be expected to shutoff all viralgeneexpression unless itsactivitywascontrolled insome way. Inthis light, modification of the protein by phosphoryla-tion or in some otherway maybe a means of inhibiting the mRNA-degradative activity of newlysynthesized copies of the protein priortotheirpackaging intoprogenyvirions. Alterna-tively, since the vhs protein degradesmRNAs inthecytoplasm while virion assemblyoccursin the nucleus, anymodifications required for transport of the protein to the nucleus and/or packaging may also be important because they lower the cytoplasmic concentration of the protein and, therefore, the amount available for mRNA degradation. Efforts are under way to test these and other models with in vitro mRNA degradation systems.ACKNOWLEDGMENTS
We thank MaryPatterson,DavidEverly,AnnetteSchmidtPak, and Charlie Krikorianforhelpful discussions and critical appraisalsof the data presented in this report. We are indebtedto Tom Holland for helpful discussions concerning the vhs function and virionpurification andtoJimSmileyandCraig Smibert forcommunicatingdatapriorto
publication. We also thank Priscilla Schaffer, Mike Levine, and Roz Sandri-Goldin forproviding viruses and plasmids.
This workwas supported by Public Health Service grantA121501 from the NationalInstituteofAllergy and Infectious Diseases.
REFERENCES
1. Anderson, K. P., R. J. Frink, G. B. Devi, B. H. Gaylord, R. H. Costa,and E. K.Wagner. 1981. Detailedcharacterization of the mRNAmapping in theHinzdIII fragment Kregion of the herpes simplexvirus type I genome. J.Virol. 37:1011-1027.
2. Atwater, J. A.,R.Wisdom,andI.Verma. 1990.RegulatedmRNA stability.Annu. Rev. Genet. 24:519-541.
3. Bell, S., M. Cranage, L. Borysiewicz, and T. Minson. 1990. Induction of immunoglobulin G Fc receptors by recombinant vaccinia virusesexpressingglycoproteinsEandIofherpessimplex virus type 1.J. Virol. 64:2181-2186.
4. Bernstein, P.,andJ.Ross.1989.Poly(A), poly(A)binding protein and the regulation of mRNA stability. Trends Biochem. Sci. 14:373-377.
5. Brawerman,G. 1989. mRNAdecay:finding the right targets. Cell 57:9-10.
6. Buchkovich, K.,L. A.Duffy,and E. Harlow. 1989.The retinoblas-tomaprotein is phosphorylated during specific phases of the cell cycle.Cell58:1097-1 105.
7. Chackalaparampil, I.,and D.Shalloway. 1988. Altered phosphor-ylation and activation of
pp6(0'-'r
duringfibroblast mitosis. Cell 52:801-810.8. Chellappan, S. P., S. Hiebert, M. Mudryj, J. M. Horowitz, and
J.R.Nevins.1991. The E2Ftranscriptionfactorisacellulartarget for the Rbprotein.Cell 65:1053-1061.
9. Cleveland, D. W. 1988. Autoregulated instability of tubulin mRNAs: anovel eukaryotic regulatory mechanism. Trends Bio-chem. Sci. 13:339-343.
10. Cleveland,D.W.,and T.J.Yen. 1989. Multiple determinants of eukaryoticmRNAstability.New Biol. 1:121-126.
11. Dawid,I.B.,and P. K.Wellauer.1976.Areinvestigationof the 5'
to3' polarityin 40S ribosomalRNAprecursor ofXenopuslaevis. Cell8:443-448.
12. Elliott,G.D.,and D. M.Meredith.1992. Theherpessimplexvirus type I tegumentproteinVP22isencodedbygeneUL49. J. Gen. Virol.73:723-726.
13. Fenwick,M.L.,andJ.Clark. 1982.Earlyanddelayedshut-off of host proteinsynthesisin cells infectedwithherpes simplexvirus. J. Gen. Virol. 61:121-125.
14. Fenwick,M. L., and R. D. Everett. 1990.Transfer ofUL41, the genecontrollingvirion-associated cellshutoff,between strains of herpessimplexvirus. J.Gen. Virol. 71:411-418.
15. Fenwick, M. L., and M. M. McMenamin. 1984. Early virion-associated suppression of cellular protein synthesis by herpes simplexvirus is accompanied by inactivation of mRNA. J. Gen. Virol. 65:1225-1228.
16. Fenwick,M. L.,L.S.Morse,and B.Roizman. 1979.Anatomyof herpessimplexvirus DNA. XI.Apparent clusteringof functions effecting rapid inhibition of host DNA and proteinsynthesis. J. Virol. 29:825-827.
17. Fenwick,M. L.,andM.J.Walker.1978.Suppressionofsynthesis of cellular macromoleculesbyherpes simplexvirus. J. Gen. Virol. 41:37-51.
18. Frink, R. J., K. P. Anderson,and E. K. Wagner. 1981. Herpes simplex virus type I HinzdIII fragment L encodes spliced and complementarymRNAspecies.J.Virol. 39:559-572.
19. Goldin,A.L.,R. M.Sandri-Goldin,M.Levine,andJ.C. Glorioso. 1981.Cloningofherpessimplexvirus type I sequences represent-ingthewhole genome. J. Virol.38:50-58.
20. Guo, L.-H.,R. P.Stepien, J.Y.Rso,R.Brousseau,S.Narang,D.Y. Thomas,and R. Wu. 1984.Synthesisof humaninsulin gene. VIII. Construction of expressionvectorsfor fusedproinsulin production in Escherichiacoli. Gene 29:251-254.
21. Harlow, E., and D. Lane. 1988.Antibodies: alaboratorymanual. ColdSpringHarborLaboratory Press,ColdSpringHarbor,N.Y. 22. Hentze,M.W. 1991. Determinants andregulationofcytoplasmic
mRNAstabilityineukaryoticcells. Biochim.Biophys.Acta1090: 281-292.
23. Hill,T.M., J.R.Sadler,andJ.L. Betz. 1985.Virion component of herpes simplexvirus type 1 KOS interferes with earlyshutoff of hostprotein synthesisinducedby herpessimplexvirustype 2 186. J. Virol. 56:312-316.
24. Johnson, D.C., and V. Feenstra. 1987. Identification ofa novel herpes simplexvirustype1-inducedglycoproteinwhichcomplexes withgEand bindsimmunoglobulin.J. Virol. 61:2208-2216. 25. Johnson,D.C.,M.C.Frame,M.W.Ligas,A.M.Cross,and N. D.
Stow. 1988. Herpessimplexvirus immunoglobulinG Fc receptor activity dependson acomplex oftwoviralglycoproteins, gE and gI.J. Virol. 62:1347-1354.
26. Karr,B.M.,and G.S.Read. 1993.Unpublished data.
27. Kmiecik,T.E., and D.Shalloway. 1987. Activation and suppres-sion ofpp6O'"-' transforming ability by mutation of its primary
sitesoftyrosine phosphorylation. Cell 49:65-73.
28. Kousoulas,K.G., D.J.Bzik, N. A.DeLuca,andS. Person. 1983. The effectofammonium chloride and tunicamycinon the glyco-protein content and infectivity of herpes simplex virus type 1.
Virology125:468-474.
29. Krikorian,C.R.,andG. S. Read. 1989. Proteins associated with mRNA in cells infected with herpes simplex virus. Biochem. Biophys. Res.Commun. 164:355-361.
30. Krikorian, C. R., and G. S. Read. 1991. An in vitro mRNA
degradation system to study the virion host shutoff function of
herpessimplexvirus. J. Virol.65:112-122.
31. Kwong,A.D.,and N.Frenkel.1987.Herpessimplexvirus-infected cells contain a function(s) that destabilizes both host and viral Vot-.67, 1993